Comparing the outcomes of parasacral transcutaneous electrical nerve stimulation for the treatment of lower urinary tract dysfunction in children: A systematic review and meta-analysis of randomized controlled trials.
child
lower urinary tract dysfunction
randomized controlled trials
urinary bladder
Journal
Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
22
09
2020
revised:
23
11
2020
accepted:
08
12
2020
pubmed:
8
1
2021
medline:
23
6
2021
entrez:
7
1
2021
Statut:
ppublish
Résumé
Despite published evidence in recent decades suggesting improvement in lower urinary tract symptoms (LUTS) with the use of parasacral transcutaneous electrical nerve stimulation (PTENS), no consensus guidelines for therapy exist. This study systematically reviews the literature to assess the effect of PTENS in children with LUTS. A database search conducted up to December 2019 included Medline, EMBASE, and the Cochrane Library. From the literature review, 6 randomized controlled studies (234 participants) comparing PTENS and standard treatment (urotherapy/anticholinergics) were considered. From each study, the success rates were available for PTENS and the control group. The ratio of success rates was computed-that is, the risk ratio (RR) and the risk difference (RD). The overall success rate with PTENS was 1.92 times that of children undergoing standard urotherapy alone (RR: 1.92, 95% confidence interval [CI: 1.02, 3.61]) and 1.56 for those undergoing either urotherapy alone or with pharmacotherapy (anticholinergics; RR: 1.56, 95% CI [1.04, 2.40]). No difference in the success rate was found when PTENS was used in patients failing previous treatment (urotherapy and pharmacological therapy; RR: 0.175, 95% CI [0.02, 1.45]). Current evidence suggests that PTENS is beneficial in children with LUTS. The chance of success is 1.92 times that of children undergoing standard urotherapy. However, in children who have failed urotherapy and pharmacological therapy, PTENS monotherapy has a limited role and should be an adjunct. Literature shortcomings included small numbers of patients, differing inclusion criteria, and PTENS protocols. A need exists for quality multicenter randomized controlled trials to prove the efficacy of PTENS in children with LUTS.
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
570-581Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Heron J, Joinson C, Croudace T, et al. Trajectories of daytime wetting and soiling in a United Kingdom 4- to 9-year-old population birth cohort study. J Urol. 2008;179(5):1970-1975.
Söderstrom U, Hoelcke M, Alenius L, et al. Urinary and faecal incontinence: a population-based study. Acta Paediatr. 2004;93(3):386-389.
de Jong TPVM, Klijn AJ, Vijverberg MAW. Lower urinary tract dysfunction in children. Eur Urol Suppl. 2012;11(2):10-15.
Borch L, Rittig S, Kamperis K, et al. No immediate effect on urodynamic parameters during transcutaneous electrical nerve stimulation (TENS) in children with overactive bladder and daytime incontinence-A randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2016;36:1788-1795.
Chang SJ, Van Laecke E, Bauer SB, et al. Treatment of daytime urinary incontinence: a standardization document from the International Children's Continence Society. Neurourol Urodyn. 2017;36(1):43-50.
Hoebeke P, Van Laecke E, Everaert K, et al. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol. 2001;166(6):2416-2419.
Bower WF, Moore KH, Adams RD. A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence. J Urol. 2001;166(6):2420-2422.
Barroso U Jr, W, Viterbo, Bittencourt J, Farias T, Lordêlo P. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children. J Urol. 2013;190(2):673-677.
Barroso U Jr, R, Tourinho, Lordêlo P, Hoebeke P, Chase J. Electrical stimulation for lower urinary tract dysfunction in children: a systematic review of the literature. Neurourol Urodyn. 2011;30(8):1429-1436.
Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society. Neurourol Urodyn. 2016;35(4):471-481.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Isabelle Boutron MJP, Higgins JPT, Altman DG, Lundh A, Hróbjartsson A.Cochrane Handbook for Systematic Reviews of Interventions. 2019. https://training.cochrane.org/handbook/current/chapter-07. Accessed April 27, 2020.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719-748.
Sato T. On the variance estimator for the Mantel-Haenszel risk difference. Biometrics. 1989;45:1323-1324.
Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1-48.
Gordon M, Lumley T. Advanced forest plot using “grid” graphics (Version 1.7. 2) [Software].
Team RC. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2013. Document freely available on the internet at: http://www.r-project.org2015
Borch L, Hagstroem S, Kamperis K, Siggaard CV, Rittig S. Transcutaneous electrical nerve stimulation combined with oxybutynin is superior to monotherapy in children with urge incontinence: a randomized, placebo controlled study. J Urol. 2017;198(2):430-435.
de Paula LIS, de Oliveira LF, Cruz BP, et al. Parasacral transcutaneous electrical neural stimulation (PTENS) once a week for the treatment of overactive bladder in children: a randomized controlled trial. J Pediatr Urol. 2017;13(3):263.
Lordêlo P, Teles A, Veiga ML, Correia LC, Barroso U. Transcutaneous electrical nerve stimulation in children with overactive bladder: a randomized clinical trial. J Urol. 2010;184(2):683-689.
Quintiliano F, Veiga ML, Moraes M, et al. Transcutaneous parasacral electrical stimulation vs oxybutynin for the treatment of overactive bladder in children: a randomized clinical trial. J Urol. 2015;193(5 Suppl):1749-1753.
Sillén U, Arwidsson C, Doroszkiewicz M, et al. Effects of transcutaneous neuromodulation (TENS) on overactive bladder symptoms in children: a randomized controlled trial. J Pediatr Urol. 2014;10(6):1100-1105.
Hagstroem S, Mahler B, Madsen B, Djurhuus JC, Rittig S. Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence. J Urol. 2009;182(4 Suppl):2072-2078.
Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society. Neurourol Urodyn. 2016;35(4):471-481.
Malm-Buatsi E, Nepple KG, Boyt MA, Austin JC, Cooper CS. Efficacy of transcutaneous electrical nerve stimulation in children with overactive bladder refractory to pharmacotherapy. Urology. 2007;70(5):980-983.
Tugtepe H, Thomas DT, Ergun R, et al. The effectiveness of transcutaneous electrical neural stimulation therapy in patients with urinary incontinence resistant to initial medical treatment or biofeedback. J Pediatr Urol. 2015;11(3):137.
Braun PM, Baezner H, Seif C, et al. Alterations of cortical electrical activity in patients with sacral neuromodulator. Eur Urol. 2002;41(5):562-567.
Gill BC, Pizarro-Berdichevsky J, Bhattacharyya PK, et al. Real-time changes in brain activity during sacral neuromodulation for overactive bladder. J Urol. 2017;198(6):1379-1385.
Weissbart SJ, Bhavsar R, Rao H, et al. Specific changes in brain activity during urgency in women with overactive bladder after successful sacral neuromodulation: a functional magnetic resonance imaging study. J Urol. 2018;200(2):382-388.